MarketCap
Facebook
X
Telegram
FSD Pharma EV/EBITDA Ratio | HUGE
Annual EV/EBITDA Ratio FSD Pharma
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.271 | -0.0423 | -0.076 | -1.52 | - | 0.111 | -1.14 | -10.7 | -21.2 | -12.6 | -17.7 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.111 | -21.2 | -6.52 |
EV/EBITDA Ratio of other stocks in the Biotechnology industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Celsion Corporation
CLSN
|
0.248 | - | -6.63 % | $ 13.9 M |  USA |
 |
Synthetic Biologics
SYN
|
-0.409 | - | 1.32 % | $ 16.2 M | USA |
 |
Dynavax Technologies Corporation
DVAX
|
4.01 K | - | - | $ 2.02 B | USA |
 |
I-Mab
IMAB
|
-37.7 | - | - | $ 866 M |  China |
 |
Corner Growth Acquisition Corp.
COOL
|
-55 | - | -0.89 % | $ 114 M | USA |
 |
AgeX Therapeutics
AGE
|
-0.164 | - | -10.17 % | $ 12.2 K | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
10.7 | - | - | $ 40.3 B | USA |
 |
Qilian International Holding Group Limited
QLI
|
-2.89 | - | -6.08 % | $ 184 M | China |
 |
Happiness Biotech Group Limited
HAPP
|
0.512 | - | 1.35 % | $ 17.8 M | China |
 |
Genfit SA
GNFT
|
4.22 K | - | 2.54 % | $ 160 B |  France |
 |
Biophytis SA
BPTS
|
-12.1 | - | -13.47 % | $ 169 M | France |
 |
CureVac N.V.
CVAC
|
-2.11 | - | - | $ 867 M |  Germany |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.42 | - | -1.52 % | $ 24.7 M | USA |
 |
Athira Pharma
ATHA
|
0.0485 | - | - | $ 269 M | USA |
 |
BiondVax Pharmaceuticals Ltd.
BVXV
|
8.55 | - | 0.74 % | $ 768 M |  Israel |
 |
Abcam plc
ABCM
|
-513 | - | - | $ 4.9 B |  Britain |
 |
Завод ДИОД
DIOD
|
7.12 | - | - | - |  Russia |
|
Galera Therapeutics
GRTX
|
2.25 | - | -32.59 % | $ 7.61 M | USA |
 |
Midatech Pharma plc
MTP
|
0.204 | - | -18.52 % | $ 27.3 M | Britain |
 |
Hepion Pharmaceuticals
HEPA
|
0.252 | - | -18.79 % | $ 39.3 K | USA |
 |
ARCA biopharma
ABIO
|
0.248 | - | 1052.0 % | $ 415 M | USA |
 |
MorphoSys AG
MOR
|
-9.67 | - | 2.43 % | $ 254 M | Germany |
 |
Codexis
CDXS
|
-4.31 | $ 1.46 | 2.82 % | $ 127 M | USA |
 |
Ardelyx
ARDX
|
-49.8 | $ 3.78 | 1.89 % | $ 911 M | USA |
 |
Affimed N.V.
AFMD
|
0.361 | - | -34.95 % | $ 21.5 M | Germany |
 |
Arcutis Biotherapeutics
ARQT
|
-316 | $ 23.9 | 1.01 % | $ 3.04 B | USA |
 |
Assembly Biosciences
ASMB
|
-25.1 | $ 36.6 | 1.3 % | $ 410 M | USA |
 |
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
-2.15 | - | -1.58 % | $ 28.1 M | China |
 |
Celyad Oncology SA
CYAD
|
0.0447 | - | - | $ 12.5 M |  Belgium |
 |
Adial Pharmaceuticals
ADIL
|
0.407 | $ 7.12 | 6.91 % | $ 4.76 M | USA |
 |
Generation Bio Co.
GBIO
|
-0.5 | - | - | $ 344 M | USA |
 |
Akero Therapeutics
AKRO
|
-10.5 | - | - | $ 3.67 B | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
0.257 | - | -4.36 % | $ 27 M | USA |
 |
Gracell Biotechnologies
GRCL
|
2.07 | - | - | $ 3.37 B | China |
 |
Axsome Therapeutics
AXSM
|
-53.8 | $ 206.68 | 0.16 % | $ 10.3 B | USA |
 |
GlycoMimetics
GLYC
|
1.15 | - | 9357.83 % | $ 1.01 B | USA |
 |
AnaptysBio
ANAB
|
26.4 | $ 56.8 | 0.94 % | $ 1.63 B | USA |
 |
Aeterna Zentaris
AEZS
|
-0.963 | - | 5.93 % | $ 314 M |  Canada |
 |
AVROBIO
AVRO
|
2.95 | - | 1083.1 % | $ 745 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
24.3 | $ 66.53 | 0.15 % | $ 12.8 B | USA |
 |
BeiGene, Ltd.
BGNE
|
-1.22 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
AIkido Pharma
AIKI
|
-45.5 | - | 1.93 % | $ 17.4 M | USA |
 |
Aeglea BioTherapeutics
AGLE
|
0.111 | - | - | $ 1.01 B | USA |
 |
Aptose Biosciences
APTO
|
1.65 K | - | -45.71 % | $ 1.2 M | Canada |
 |
Bicycle Therapeutics plc
BCYC
|
0.703 | $ 4.3 | 1.42 % | $ 298 M | Britain |
 |
AlloVir
ALVR
|
1.19 | - | 4.14 % | $ 49.1 M | USA |
 |
ChromaDex Corporation
CDXC
|
-2.07 | - | -0.88 % | $ 598 M | USA |